Sort
30,917 grants matching “tumor microenvironment”
Novel Markers for Disease Outcome in Breast Cancer
$673,686Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
An organotypic model recapitulating colon cancer microenvironment and metastasis
$673,627Emina Hui-Na Huang · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$673,611Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA
CD200R blockade for cancer immunotherapy
$673,569Sujit Basu · Ohio State University · R01 · FY2025 · CA
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer
$673,463Lin Z Li · University Of Pennsylvania · R01 · FY2025 · CA
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$673,408Antonio M Omuro · Yale University · R01 · FY2023 · CA
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
$673,220Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2021 · CA
Studying phenotypic states of antitumor human T cells
$673,212Sri Krishna · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Early detection and risk of head and neck cancer through immune based spatial omics
$673,156Sara Isabel Pai · Yale University · U01 · FY2024 · DE
Multicolor PET to interrogate cancer biology
$673,118Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2025 · EB
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$673,034Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · DE
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$672,991Daniel J. Powell · University Of Pennsylvania · R01 · FY2022 · CA
Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer
$672,853Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2024 · CA
Targeting MIC to Augment Adoptive NK Therapy Using the Canine Soft Tissue Sarcoma Model
$672,844Seth M Pollack · Northwestern University At Chicago · R01 · FY2025 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$672,673Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2025 · CA
Fibronectin Modulation of Oral Cancer Nociception
$672,660Aditi Bhattacharya · New York University · R56 · FY2025 · DE
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$672,634Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Genetically engineered mouse model to improve therapy of NUT carcinoma
$672,468Christopher A French · Brigham And Women'S Hospital · R01 · FY2023 · CA
Ultra-sensitive mass spectrometry-based immunopeptidomics using digital microfluidics.
$672,371Etienne Caron · Yale University · R61 · FY2025 · CA
Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal Malignancies
$672,300Pavlos Msaouel · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal Malignancies
$672,300Pavlos Msaouel · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Targeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitor
$672,297David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$672,254Deborah W Knapp · Purdue University · U01 · FY2025 · CA
The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities
$672,210Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2020 · CA
PD-1/PD-L1 modulation in cancer therapy
$672,206Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · CA